U.S.-listed biotech buyers continued to favor asset deals over multi-billion-dollar company takeovers this week.
U.S. stock indices ended lower on Friday, with the S&P 500 and Nasdaq also closing the month lower after investors moved out ...
Pure-EV player Rivian delivered a clear third-quarter beat and raised its 2026 delivery outlook on the back of early R2 ...
The FDA granted accelerated approval to Inovio Pharmaceuticals’ (INO) Voceryq, a plasmid DNA-based immunotherapy for adults ...
Talks remain ongoing and a deal may not materialize, the report said, while adding that any transaction would likely include ...
Higher Rates Ahead? Three Fed Officials Have Called For A Gradual Uptick In Interest Rates This Week
Top Federal Reserve officials signaled this week that further interest rate increases will be required to control persistent ...
According to an Investing.com report, BofA said Tesla’s Shanghai plant would come under the ownership of a major U.S. defense ...
Bank of America guided investors toward mega-cap technology corporate bonds instead of equities as an investment opportunity.
Analysts turned bullish on Eli Lilly (LLY) on Friday, betting on its obesity-drug leadership and expanding pipeline.
DoorDash (DASH) and Instacart (CART) drew investor attention on Friday after multiple analysts revised their ratings and ...
Amazon.com Inc. (AMZN) has arranged up to $80 billion in supplier financing credit line as it prepares for aggressive ...
Bitcoin (BTC) fell to a six-week low in morning trade on Friday after a reported $6.3 billion hack at Binance, triggering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results